#26 Pharmacotherapy for Smoking: What works and what to consider (PART I)?
CLINICAL QUESTION
In patients ready to make a smoking cessation attempt, how effective are registered first-line medications and what are the potential concerns?
BOTTOM LINE
There are four first-line options of nicotine replacement therapy (NRT) (gum, patch, lozenge or inhaler) and all improve the chance of abstinence from smoking. For every 17 patients treated with NRT, one will remain abstained from smoking at six months. Adverse events are low but supportive follow-up will allow monitoring and can improve cessation.
Reading Tools for Practice Article can earn you MainPro+ Credits
Join NowAlready a CFPCLearn Member? Log in
EVIDENCE
Part I reviews Nicotine Replacement Therapy (NRT) and related issues Part II discusses antidepressants and varenicline
- NRT: Cochrane systematic review1 of 150 randomized controlled trials (RCTs):
- Overall Risk Ratio (RR) of abstinence: 1.60 (1.53 to 1.68).
- Gum: 1.49 (1.40 - 1.60, 55 trials).
- Patch: 1.64 (1.52 - 1.78, 43 trials).
- Inhaler: 1.90 (1.36 - 2.67, 4 trials).
- Lozenge: 1.95 (1.61 - 2.73, 6 trials).
- Some evidence combining rapid-acting NRT with patch can offer small advantage over monotherapy: RR 1.34 (1.18-1.51, 9 trials).
- There is no difference in efficacy between NRT and bupropion: RR 1.01 (0.87- 1.18).
- Adverse events:
- Local irritation relates to the type of product.
- No evidence that NRT increases myocardial infarctions.
- Overall Risk Ratio (RR) of abstinence: 1.60 (1.53 to 1.68).
- Assuming placebo cessation rates of 10% (mean across studies), the number needed to treat (NNT) for NRT therapy is approximately 17 (range 15-19).
- Smoking cessation is the most effective preventive maneuver for conditions including COPD, cancer and cardiovascular disease.
- For example, an RCT2 of aggressive smoking cessation intervention for 209 patients after CCU admission 2 years later resulted in:
- 39% quitting versus 9%.
- 3% mortality versus 12%, for a 9% absolute reduction (NNT 11).
- For comparison, ASA provides a 1.4% reduction (NNT 72) in mortality in a similar population and time frame.3
- For example, an RCT2 of aggressive smoking cessation intervention for 209 patients after CCU admission 2 years later resulted in:
- Pharmacotherapy is safe and effective in a broad range of populations, including the mentally ill.
- Combining counseling and support with pharmacotherapy improves outcomes.1
Latest Tools for Practice
#370 Antibiotics or no antibiotics for acute diverticulitis, that is the question!
Do antibiotics change clinical outcomes for patients with acute uncomplicated diverticulitis?
#369 Remind me, do medications that target brain amyloid improve my dementia?
Are amyloid-targeting monoclonal antibodies safe and effective for mild cognitive impairment or Alzheimer’s dementia?
#368 Sodium Restriction in Heart Failure: Beneficial or pouring salt in the wound?
Does sodium restriction improve outcomes in patients with chronic heart failure?
